Dunning R3327 AT-1 rat prostate tumor cells were transfected with a double-fusion suicide gene (CDglyTK) that coded for the cytosine deaminase from E. coli and the thymidine kinase (TK) from HSV-1. The resulting cell line AT-1/CDglyTK was incubated with 10 and 20 mg/ml 5-FC or 0.25 mg/ml GCV, or both 5-FC and GCV 96 hours before harvest. The MTS assay detected cell viabilities of 5075 and 2575% after 5-FC treatment, and 5075% after GCV treatment. The dye exclusion and the colony-forming assay confirmed the data of the MTS assay with GCV (4775 and 3275%), but presented different results for the 5-FC incubation. We detected 10071 and 8575% viable cells after 10 mg/ml 5-FC, and 9771 and 8575% after 20 mg/ml 5-FC treatment, respectively. S-phase arrest in both suicide gene systems was noticeable and a significant increase in cell granularity was observed after incubation with GCV or GCV & 5-FC. This study demonstrates that 5-FC and the metabolized 5-FU act not only as genotoxic reagents, but also as RNA-directed agent, because of the recovery of the cells. On the other hand, a significant S-phase block could be observed after 24 hours incubation with GCV. This short time is enough to incorporate the genotoxic GCV metabolites in the nascent DNA to impair the cell cycle.
I
n normal cells, a balance between proliferation and cell death is achievable. The cell cycle progression is affected by environmental stimuli and metabolic perturbations. One strategy of the suicide gene therapeutic approach is the obstruction of the cell cycle progression with cytotoxic drugs.
The herpes simplex virus type-1 thymidine kinase (HSV-1 TK) is one of the most studied suicide genes. HSV-1 TK enzyme converts the nontoxic antiviral nucleotide analogue ganciclovir (GCV) to GCV-monophosphate (GCV-MP), which is finally phosphorylated by endogenous cellular kinases to GCV-triphosphates (GCV-TP). GCV-TP is then incorporated into the nascent DNA strands during the S-phase, and this results in basepair mismatches, DNA fragmentation, sister chromatid exchange and lethal genomic instability. 1, 2 A well-studied alternative gene therapy involves the transfection of tumor cells with the cytosine deaminase (CD) gene from Escherichia coli. Cytosine deaminase is found in some bacteria and fungi, but is absent in mammalian cells. CD deaminates cytosine to uracil and is able to deaminate the relatively nontoxic pyrimidine derivative 5-fluorocytosine (5-FC, 5-FCyt, flucytosine) to the highly potent chemotherapeutic agent 5-fluorouracil (5-FU, 5-FUra), 3 used in the treatment of many cancers. 4, 5 Cellular enzymes subsequently metabolize 5-FU to cytostatic/cytotoxic fluoronucleotides such as FUTP and FdUMP. 6 5-FU acts throughout the cell cycle with emphasis on certain events such as DNA synthesis. When cells were incubated continuously with 5-FU, most of them accumulated in S-phase and remained there. 7 In this study, we examined the mechanism of the cytotoxic effects of CD/5-FC and TK/GCV in the Dunning rat prostate adenocarcinoma cell line R3327 AT-1, which was transfected with a double-suicide gene for the fusion protein CDglyTK (bacterial CD from E. coli, TK from HSV-1). Most current assays for measuring viability are based on alterations of plasma membrane permeability and the consequent leakage of components into the supernatant or the uptake of dyes, normally excluded by viable cells. Alternatively, dead cells are unable to metabolize various tetrazolium salts like MTS (3-(4,5-dimethyltiazol-2-yl)-5-(3-carboxy-methoxy-phenyl)-2-(4-sulfophenyl)-2H-tetrazolium), which allows the measurement of cell survival. 8 Apoptosis, however, is an active mode of cell death requiring the metabolism of cells. Thus, like the permeability assay mentioned above, the MTS assay may underestimate cellular damage and detect cell death only at the later stages of apoptosis when the metabolic activity of the cells is reduced. Colony formation at low cell density is the preferred method for analysing cell proliferation and survival. This technique reveals differences in the growth rate within a population and distinguished between alterations in the growth rate (colony size) and cell survival (colony number). 9 We used the propidium iodide exclusion-, the MTSand the colony forming assay to characterize the pathway of cell death after prodrug incubation. In the past, some studies reported that HSV-1 infections, 5-FU or suicide gene systems lead to a cell cycle arrest in the S-phase and to apoptosis. [10] [11] [12] [13] [14] [15] In both suicide gene systems, an S-phase arrest could be observed, but only the GCV-treated cells illustrated comparable results, measured with different assays. Diversity assays were necessary to get reliable data on 5-FC-treated CDglyTK þ cells.
Material and methods

Cell lines
The Dunning prostate adenocarcinoma cell line R3327 AT-1 was originally derived from a spontaneous prostate tumor in a male Copenhagen rat. AT-1 is a slow-growing, nonmetastatic, anaplastic and hormone-insensitive tumor with a histology and biochemical profile similar to those of human prostate carcinomas. 16 The cell line was obtained in 1987 from Dr JT Isaacs (John Hopkins University, Baltimore, MD), and has been maintained in the DKFZ tumor bank.
AT-1 cells transfected with a bifunctional fusion gene, pWZLneoCDglyTK, coded for a fusion protein, comprising cytosine deaminase (CD) from E. coli and thymidine kinase (TK) from HSV-1 linked via a glycine spacer (kindly provided by JH Kim (Henry Ford Hospital, Detroit)). 17 CDglyTK þ cells were selected by culturing in the presence of 0.5 mg/ml geneticin (G418, Gibco BRL) because of the neomycin resistance gene. Expression of the CDglyTK fusion protein was confirmed by binding of a polyclonal anticytosine deaminase antibody. 18 The protein-antibody complex was stained with the aid of 3,3 0 -diaminobenzidine (DAB) (Vector Laboratories) and visualized under the microscope as granula distributed throughout the cytoplasm.
AT-1 and transfected AT-1 cell lines were grown in Roswell Park Memorial Institute medium (RPMI 1640, Sigma) supplemented with 10% heat-inactivated fetal calf serum (FCS, Sigma) and 2 mM glutamine (Sigma). Cells were cultured in 25-cm 2 flasks (Greiner) at 371C under 5% CO 2 and 95% humidity.
MTS cell proliferation assay
The sensitivities of AT-1 and transfected cells to 5-FC and GCV were quantified using a colorimetric CellTiter 96 
Colony-forming assay
Cells were seeded 4 hours prior to prodrug treatment. The number of plated cells was selected to be in a range, which ensured a linear relationship between the number of cells plated and the number of colonies formed. The prodrug incubated cells (10 and 20 mg/ml 5-FC, 0.25 mg/ml GCV, Mix (1): 10 mg/ml 5-FC and 0.25 mg/ml GCV and Mix (2): 20 mg/ml 5-FC and 0.25 mg/ml GCV) were stained with crystal violet and colonies of 450 cells were counted after 6 days. The fraction of survivors relative to the original number of cells seeded was calculated (plating efficiency) and then normalized to the untreated plating efficiency to determine the surviving fraction. Each point was an average of three flasks, and each assay was performed three times.
Dye-exclusion assay and granularity measurements
The assays were performed using 25 cm 2 cell culture flasks seeded with 10 5 cells in 5 ml of RPMI 1640. The prodrug incubation followed cell seeding 4 hours later (10 and 20 mg/ml 5-FC, 0.25 mg/ml GCV, Mix (1): 10 mg/ml 5-FC and 0.25 mg/ml GCV and Mix (2): 20 mg/ml 5-FC and 0.25 mg/ml GCV). After 96 hours cells were trypsinated and combined with the collected supernatant. For each sample, 500 ml of cell suspension with 5 mg/ml propidium iodide (Sigma) was measured in the FACScalibur in fluorescence channel 2 in the logarithmic mode, forward scatter and side scatter in the linear mode. For each measurement, 10,000 cells were collected and analyzed with the cell quest software (Becton Dickinson).
Acridine orange staining 1 Â 10 5 cells were seeded on object slides in quadriPERM flaks (Heraeus Instruments, Osterode am Harz, Germany) 4 hours prior to prodrug treatment (10 and 20 mg/ ml 5-FC and 0.25 mg/ml GCV). After 96 hours, the unfixed cells were incubated with acridine orange (1 mg/ ml, Sigma) for 1 minutes and directly visualized by fluorescence microscopy using a Nikon Eclipse E600 microscope.
Cell cycle analysis
Asynchronously growing cells were exposed to 10 and 20 mg/ml 5-FC, 0.25 mg/ml GCV or a mixture of both prodrugs (Mix (1): 10 mg/ml 5-FC and 0.25 mg/ml GCV, Mix (2): 20 mg/ml 5-FC and 0.25 mg/ml GCV). Analyses
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were performed using a Galaxy pro flow cytometer (Partec, Mu¨nster, Germany) equipped with a mercury vapor lamp (100 W) and a filter combination for the detection of cells stained with 2,4-diamidino-2-phenylindole (DAPI) and a 488 nm laser with filter combination for FITC. Single cells were isolated using 2.1% citric acid/ 0.5% tween-20 according to the method of Otto, 19 followed by slight shaking at room temperature. For staining, cell suspensions were incubated in phosphate buffer (7.2 g Na 2 HPO 4 Â 2H 2 O in 100 ml H 2 O dist.) of pH 8.0 containing DAPI. Each histogram represents 30,000-100,000 cells for measuring the DNA index and cell cycle. Histogram analysis was performed with the Multicycle program (Phoenix Flow Systems, San Diego, CA).
Data analysis and statistics
The statistical significance of differences between groups was estimated as the P-value for a two-tailed t-test, assuming unequal variance (Microcal Origin Version 6.0).
Results
Cytotoxic effects of the CD/5-FC and TK/GCV systems measured with different methods
The experiments described in this report were performed using two rat prostate tumor cell lines (see Material and methods): the parental AT-1 cell line (Dunning R3327 AT-1 rat prostate adenocarcinoma), and the transfected cell line AT-1/CDglyTK containing a double-suicide gene coding for the fusion protein cytosine deaminase (E. coli) plus thymidine kinase (Herpes simplex virus Type 1). The sensitivities of the cell lines to 5-FC and GCV were examined under standard culture conditions.
The metabolic activity of prodrug-treated cells was investigated in an MTS proliferation assay as a function of time. The parental AT-1 line, which does not express cytosine deaminase and thymidine kinase, exhibited no growth inhibition at the tested concentrations (Fig 1a, b) . In contrast, AT-1/CDglyTK showed a significant metabolic reduction at various prodrug concentrations. For example, after 96 hours of incubation with the prodrugs, an B50% reduction was observed in comparison to the untreated control at a concentration of 10 mg/ml 5-FC and 0.20 mg/ml GCV (Fig 1c, d ). An incubation period of minimum 48 hours is necessary to observe an effect at any tested 5-FC concentration. The GCV-treated cells needed 24 hours longer (72 hours) to exhibit a considerable metabolic reduction.
In a colony-forming assay, we determined the plating efficiency of AT-1 and AT-1/CDglyTK cells. Cells were exposed to 5-FC, GCV, or both 5-FC and GCV. The cytopathic effect was scored quantitatively by staining cells 6 days after prodrug contribution. At doses of 10 and 20 mg/ml 5-FC, the survival fraction in comparison to an untreated control was for both concentrations 8575%. At a concentration of 0.25 mg/ml GCV (IC 50(MTS) ) alone or in combination with 5-FC (10 and 20 mg/ml), survival fractions of 3275, 2373 and 1271%, respectively, were detectable. The AT-1 cell line showed no growth inhibition at any tested concentration of the prodrugs (Fig 2) .
In a dye-exclusion assay with propidium iodide, no marked differences between the control and the 5-FCtreated cells were found, illustrated in Figure 3 . Almost all cells showed an intact cytoplasm membrane, and therefore all cells were viable. The cell viability was significantly inhibited in cultures treated with 0.25 mg/ml GCV (4775% viability) compared with untreated control Table 1 .
Analysis of the cell cycle
DNA flow cytometry demonstrated perturbations of the AT-1/CDglyTK cell cycle following prodrug exposure.
An S-phase arrest was the result of the treatment after a 96 hours continuous incubation with prodrugs (Fig 4a) . Cells which were incubated for 24 hours with 0.25 mg/ml GCV, Mix (1): 10 mg/ml 5-FC and 0.25 mg/ml GCV and Mix (2): 20 mg/ml 5-FC and 0.25 mg/ml GCV, and then cultured further with fresh medium, showed a reduction of the G 0 /G 1 -phase, as well as an increase of the S-phase (Fig 4b) . The prodrugs had no influence on the cell cycle of the AT-1 cells (Fig 4c, d ). Both cell lines exhibited a classical cell cycle pattern in control drug-free medium, with G 1 and G 2 peakd divided by cells in the S-phase.
Acridine orange staining
Acridin orange (AO) stains DNA (double-stranded) yellow-green, RNA and single-stranded DNA, red. 
Discussion
Different methods were compared to achieve the cytotoxic effects of 5-FC and GCV in the Dunning R3327 AT-1 rat prostate tumor cell line and in the double-suicide gene transfected cell line AT-1/CDglyTK. As proliferating cells are metabolically more active than nonproliferating (resting) cells, the MTS assay is suitable not only for the determination of cell viability and factormediated cytotoxicity, but also for the determination of cell activation and proliferation. 8 In this assay, only the CDglyTK þ cell line exhibited sensitivities to 5-FC and GCV after 96 hours of incubation (Fig 1c, d) . In the following colony-forming assay and dye-exclusion assay, the employed prodrug concentrations were the evaluated IC 50 from the MTS assay. The survival fraction of GCVtreated cells was 3275%, which is less than that in the (2)), 0.25 mg/ml GCV, 10 mg/ml 5-FC and 0.25 mg/ml GCV (Mix (1)) and 20 mg/ml 5-FC and 0.25 mg/ml GCV (Mix (2)). The graph indicates the plating efficiencies relative to the plating efficiencies formed by an untreated control, which were set to 1. Each data point is the average of three independent experiments, with each treatment condition performed in triplicate flasks. The error bars represent the standard error of mean; *Po.001 two-tailed t-test. Percentage of viable cells relative to an untreated control. Mix 1: 0.25 mg/ml GCV+10 mg/ml 5-FC; Mix 2: 0.25 mg/ml GCV+20mg/ ml 5-FC.
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other two assays, because of the longer incubation time (144 hours). Measures of 10 and 20 mg/ml 5-FC-treated cells exhibited a clonogenic survival of about 8575%. After PI staining and GCV incubation, 4775% viable cells were counted, which is comparable to the results achieved in the MTS assay. 5-FC-treated CDglyTK þ cells behave entirely different. Almost all cells had an intact cytoplasm membrane, and so we detected a cell viability of 97%-100% (Fig 3) with the dye-exclusion assay. We expected lower cell viability measured with the PI uptake, because the MTS assay normally underestimates the cellular damage and detects cell death only at later stages of apoptosis. These tests imply that 5-FC decreases the metabolic activity of the cells, and thus the cytotoxic effect is perhaps reversible; otherwise, a reduced cell survival should be observed.
Cory et al 21 demonstrated that, after an incubation of mouse leukaemia L1210 cells with 5-fluoro-2 0 -deoxyuridine (5-FdUrd), the IC 50 values, measured with a MTS assay, compared very favorable with IC 50 values obtained by direct cell counting. 5-FdUrd acts as an inhibitor of the thymidylate synthase and can be incorporated in the nascent DNA (5-FU-DNA). Consequently, 5-FdUrd can operate as a genotoxic substrate. Accordingly, we concluded that a genotoxic event can be detected with an MTS or a dye-exclusion assay, like GCV or 5-FdUrd.
Continuous incubation with any of the tested prodrugs showed a significant S-phase arrest after 96 hours of incubation. A lack of cell cycle perturbations after 24 hours incubation with 5-FC treatment suggests that the metabolized 5-FU induces an alternative pathway, which does not trigger a cell cycle arrest. It is possible that the metabolized 5-FU can be incorporated in a nascent RNA. The levels of nascent pre-mRNA were not influenced by exposure to 5-FU, but mature mRNA declined by relatively modest concentrations of 0.13 mg/ml 5-FU. 22 In another experiment, 23 we incubated AT-1 and AT-1/CDglyTK cells for 24 hours with various concentrations of 5-FU (IC 50(MTS) ¼ 0.4 mg/ml), and then cultured further with fresh medium. Both cell lines showed essentially the same behavior. At 5-FU concentrations of 0.5 and 0.75 mg/ml, about 50% growth inhibition was observed for 24-48 hours after drug removal, but cell counts approached control levels after a further 24 hours. With 1.0 or 2.0 mg/ml 5-FU, both cell lines showed growth inhibitions of 70-80% at 24 hours after treatment, but even at the highest dose a slow growth recovery was observed 3 days after treatment. However, the results indicate that 5-FU concentrations above 1 mg/ml and exposure times of longer than 24 hours will be necessary for an effective cell kill. This demonstrates that 5-FC and 5-FU act not only as genotoxic reagents, but also as RNA-directed agents, because of the fast recovery of the cells. On the other hand, a significant S-phase block could be observed after 24 hours incubation with GCV. This short time is enough to incorporate the genotoxic GCV metabolites in the nascent DNA.
Forward and side scatter flow cytometry has been suggested as a complementary technique for studying the mechanisms of cell damage. 24, 25 The results of our Figure 4 Cell cycle phases of AT-1/CDglyTK (a, b) and AT-1 (c, d) cells, which were exposed to 10 mg/ml 5-FC (FC(1)), 20 mg/ml 5-FC (FC(2)), 0.25 mg/ml GCV, 10 mg/ml 5-FC and 0.25 mg/ml GCV (Mix(1)) and 20 mg/ml 5-FC and 0.25 mg/ml GCV for 96 and 24 hours (Mix(2)). The graph indicates the percentage of cells, which were in G 0 /G 1 -, S-and G 2 /M-phase. Cells from three experiments were pooled due to the low cell number.
cytometric analysis maintain the theory of apoptosis rather than necrosis, since a decrease in cell size and an increase in granularity are signs of apoptosis. GCV alone or in combination with 5-FC exhibits a significant increase in granularity of 15-20% in the lower right and 35-40% in the upper right in comparison to control and 5-FC-treated cells (data not shown). This is clear evidence for an apoptotic cell death, which is also seen after acridine orange staining. Undergoing AT-1 cells, as apoptotic or necrotic cells, could not be detected with any of the methods applied. An additive/synergistic effect of 5-FC and GCV was detectable with the dye-exclusion and the colony-forming assay. In the dye-exclusion assay, GCV alone reduced the viable cells to an amount of 4775% and in combination with 20 mg/ml 5-FC to 3571%. A more significant effect was observed in the colony-forming assay. A reduction of 2373 and 1271% was obtained in combination with 0.25 mg/ml GCV and 10 mg/ml 5-FC or 20 mg/ml 5-FC, respectively. Similar results were detected in a human prostate carcinoma cell line, LNCaP, measured with an MTS assay. 26 Yoshimura et al 26 observed a reduction of 17% in cell viability when two suicide genes were combined. This additive/synergistic effect may be a result of the impaired DNA synthesis 27 combined with the incorporated triphosphorylated GCV in the nascent DNA as a false guanosine nucleotide, which is a poor substrate for continued chain elongation. 1,2,28 Aghi et al 29 reported that treatment of 9L/CD-TK rat gliosarcoma cells with 5-FC could reduce the intracellular thymidine concentration enough to substantially lower the fraction of HSV TK active sites occupied by thymidine. This effect could release enough HSV TK active sites for GCV to bind, thus favouring the rate-limiting reaction in GCV treatment.
In conclusion, we have demonstrated that it is very important which kind of assay is chosen to study a cytotoxic effect in suicide gene systems. We have also shown that the CD/5-FC cell killing is very complex and that the cells are able to recover during the treatment. Therefore, not every toxicological assay is appropriate to measure cell survival. 
